tiprankstipranks
Trending News
More News >
Poniard Pharmaceuticals (PARD)
OTHER OTC:PARD
US Market
Advertisement

Poniard Pharmaceuticals (PARD) Similar Stocks

Compare
7 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Poniard Pharmaceuticals
$0.31
672.50%
Scinai Immunotherapeutics
$1.20
$963.88K
0.23
-63.64%
PainReform
$0.96
$2.11M
>-0.01
-71.34%
0 Buy
0 Hold
0 Sell
Hold
MSP Recovery
$0.32
$996.00K
-98.59%
0 Buy
0 Hold
0 Sell
Moderate Sell
NewcelX
$3.64
$1.63M
-83.30%
Virax Biolabs Group Ltd. Class A
$0.63
$2.21M
-0.31
-65.82%
0 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PARD
Poniard Pharmaceuticals
SCNI
Scinai Immunotherapeutics
1.20
-2.16
-64.29%
PRFX
PainReform
0.96
-2.41
-71.51%
MSPR
MSP Recovery
0.32
-15.78
-98.01%
NCEL
NewcelX
VRAX
Virax Biolabs Group Ltd. Class A
0.63
-1.21
-65.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis